ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,564,589 | -38.5% | 207,093 | -18.3% | 0.04% | -34.0% |
| Q2 2023 | $9,044,161 | +42.1% | 253,622 | +1.2% | 0.05% | +32.5% |
| Q1 2023 | $6,364,757 | -36.2% | 250,581 | +1.9% | 0.04% | -38.5% |
| Q4 2022 | $9,977,801 | +37.5% | 246,001 | +12.0% | 0.06% | +30.0% |
| Q3 2022 | $7,257,000 | +1189.0% | 219,588 | +1272.9% | 0.05% | +1150.0% |
| Q2 2022 | $563,000 | -23.5% | 15,995 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $736,000 | -30.6% | 15,995 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,060,000 | +6.1% | 15,995 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $999,000 | -32.3% | 15,995 | -10.2% | 0.01% | -37.5% |
| Q2 2021 | $1,475,000 | +2.4% | 17,807 | -18.1% | 0.01% | 0.0% |
| Q1 2021 | $1,441,000 | -13.6% | 21,737 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $1,668,000 | +78.2% | 21,737 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $936,000 | -74.8% | 21,737 | -74.7% | 0.01% | -75.0% |
| Q2 2020 | $3,715,000 | -33.6% | 86,017 | -55.8% | 0.02% | -40.0% |
| Q1 2020 | $5,594,000 | -68.4% | 194,450 | -30.3% | 0.04% | -50.0% |
| Q4 2019 | $17,703,000 | +159.4% | 279,090 | +15.2% | 0.08% | +158.1% |
| Q3 2019 | $6,824,000 | +52.5% | 242,175 | +43.4% | 0.03% | +55.0% |
| Q2 2019 | $4,474,000 | +89380.0% | 168,830 | +5381.5% | 0.02% | – |
| Q2 2017 | $5,000 | – | 3,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |